TEVA PHARMACEUTICAL INDUSTRIES LIMITED Retained Earnings
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Retained Earnings of -$13.97 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-29
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$13.97B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$13.39B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$13.76B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$14.24B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$13.97B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | -$13.39B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | -$13.76B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | -$14.24B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | -$14.68B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | -$14.96B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | -$15.17B 10-K · filed 2026-02-03 | |
| 2024-09-30 | -$14.96B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | -$14.52B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | -$13.67B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$13.53B 10-K · filed 2025-02-05 | |
| 2023-09-30 | -$13.99B 10-Q · filed 2024-11-06 | -$13.87B 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$14.07B 10-Q · filed 2024-07-31 | -$13.95B 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$13.19B 10-K · filed 2024-02-12 | -$13.09B 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$12.97B 10-K · filed 2024-02-12 | -$12.88B 10-K · filed 2023-02-10 |
| 2022-09-30 | -$11.67B 10-K · filed 2024-02-12 | -$11.66B 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$11.73B 10-K · filed 2024-02-12 | -$11.72B 10-Q · filed 2022-07-27 |
| 2022-03-31 | -$11.48B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | -$10.53B 10-K · filed 2023-02-10 | |
| 2021-09-30 | -$10.37B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | -$10.66B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | -$10.87B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | -$10.95B 10-K · filed 2022-02-09 | |
| 2020-09-30 | -$11.10B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$6.75B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | -$6.89B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$6.96B 10-K · filed 2021-02-10 | |
| 2019-09-30 | -$7.07B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$6.75B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | -$6.06B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | -$5.96B 10-K · filed 2020-02-21 | |
| 2018-09-30 | -$3.07B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | -$2.86B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | -$2.69B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | -$3.80B 10-K · filed 2019-02-19 | |
| 2017-09-30 | $7.87B 6-K · filed 2017-11-02 | |
| 2017-06-30 | $7.43B 6-K · filed 2017-08-03 | |
| 2017-03-31 | $13.81B 6-K · filed 2017-05-11 | |
| 2016-12-31 | $13.61B 10-K · filed 2018-02-12 | |
| 2016-09-30 | $14.99B 6-K · filed 2016-11-15 | |
| 2016-06-30 | $14.99B 6-K · filed 2016-08-04 | |
| 2016-03-31 | $15.11B 6-K · filed 2016-05-09 | |
| 2015-12-31 | $14.85B 20-F · filed 2017-02-15 | |
| 2015-09-30 | $14.66B 6-K · filed 2015-10-29 | |
| 2015-06-30 | $14.84B 6-K · filed 2015-07-30 | |
| 2015-03-31 | $14.59B 6-K · filed 2015-04-30 | |
| 2014-12-31 | $14.44B 20-F · filed 2016-02-11 | |
| 2014-09-30 | $14.02B 6-K · filed 2014-10-30 | |
| 2014-06-30 | $13.44B 6-K · filed 2014-07-31 | |
| 2014-03-31 | $12.99B 6-K · filed 2014-05-02 | |
| 2013-12-31 | $12.54B 20-F · filed 2015-02-09 | |
| 2013-09-30 | $12.43B 6-K · filed 2013-10-31 | |
| 2013-06-30 | $11.99B 6-K · filed 2013-08-01 | |
| 2013-03-31 | $12.71B 6-K · filed 2013-05-02 | |
| 2012-12-31 | $12.35B 20-F · filed 2014-02-10 | |
| 2012-09-30 | $12.25B 6-K · filed 2012-11-01 | |
| 2012-06-30 | $12.54B 6-K · filed 2012-08-02 | |
| 2012-03-31 | $11.91B 6-K · filed 2012-05-09 | |
| 2011-12-31 | $11.28B 20-F · filed 2013-02-12 | |
| 2011-09-30 | $10.97B 6-K · filed 2011-11-02 | |
| 2011-06-30 | $10.26B 6-K · filed 2011-07-28 | |
| 2011-03-31 | $9.88B 6-K · filed 2011-05-11 | |
| 2010-12-31 | $9.32B 20-F · filed 2012-02-17 | |
| 2010-09-30 | $8.73B 6-K · filed 2010-11-02 | |
| 2010-06-30 | $7.84B 6-K · filed 2010-07-27 | |
| 2010-03-31 | $7.21B 6-K · filed 2010-05-04 | |
| 2009-12-31 | $6.66B 20-F · filed 2011-02-15 | |
| 2009-09-30 | $6.42B 6-K · filed 2009-11-03 | |
| 2009-06-30 | $5.90B 6-K · filed 2009-07-29 | |
| 2009-03-31 | $5.51B 6-K · filed 2009-05-07 | |
| 2008-12-31 | $5.19B 20-F · filed 2010-02-22 |